Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Nephrology 3, 466 (1 September 2007) | doi:10.1038/ncpneph0550
Eprodisate slows renal function decline in AA amyloidosis
Abstract
Dember LM et al. (2007) Eprodisate for the treatment of renal disease in AA amyloidosis. N Engl J Med 356: 2349–2360 Deposition of fibrils in the kidneys of patients with amyloid A (AA) amyloidosis can lead to proteinuria and progressive loss of renal function.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
